Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Curent Deferred Tax Liability Current Assets Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Growth Metrics

Others

Teva Pharmaceutical Industries (TEVJF) Receivables - Other (2023)

Historic Receivables - Other for Teva Pharmaceutical Industries (TEVJF) over the last 2 years, with Q4 2023 value amounting to $1.0 million.

Teva Pharmaceutical Industries' Receivables - Other changed N/A to $1.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2023, which is N/A changed from last year.
As of Q4 2023, Teva Pharmaceutical Industries' Receivables - Other stood at $1.0 million.
Teva Pharmaceutical Industries' 5-year Receivables - Other high stood at $1.0 million for Q4 2023, and its period low was $1.0 million during Q4 2023.